Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Claudio Cavazza currently holds 12,937,111 shares of SCICLONE PHARMACEUTICALS INC (SCLN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Claudio Cavazza has been a net buyer of SCLN stock. They have purchased $19.8M and sold $0 worth of shares.
Claudio Cavazza's most recent insider trade was on Jan 5, 2011, when they purchased 925,926 shares at $0.27 per share.
Claudio Cavazza serves as Executive at SCICLONE PHARMACEUTICALS INC (SCLN). They have executed 38 insider transactions totaling $19.8M over their tenure at the company.
Claudio Cavazza holds the position of Executive at SCICLONE PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Claudio Cavazza has shown a buying trading pattern, with $19.8M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Claudio Cavazza was on Feb 11, 2009, when they purchased $4.5M worth of DORB shares. This transaction involved 25,000,000 shares at $0.18 per share.
Claudio Cavazza currently owns 12,937,111 shares of SCICLONE PHARMACEUTICALS INC (SCLN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Claudio Cavazza's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Claudio Cavazza has 38 Form 4 filings on record as an insider at SCICLONE PHARMACEUTICALS INC.
Set alerts for Claudio Cavazza and 40,000+ other insiders.